BRL 31.96
(-0.19%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 10.25 Billion BRL | -0.08% |
2022 | 6.02 Billion BRL | 83.05% |
2021 | 5.05 Billion BRL | -56.88% |
2020 | 2.66 Billion BRL | 203.99% |
2019 | 3.55 Billion BRL | -2.99% |
2018 | 2.6 Billion BRL | 53.43% |
2017 | 2.16 Billion BRL | 26.67% |
2016 | 1.9 Billion BRL | 19.09% |
2015 | 1.58 Billion BRL | 90.58% |
2014 | 851.33 Million BRL | 33.86% |
2013 | 611.74 Million BRL | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 2.7 Billion BRL | -16.04% |
2024 Q2 | 2.81 Billion BRL | 4.16% |
2023 FY | - BRL | -0.08% |
2023 Q1 | 2.66 Billion BRL | 46.36% |
2023 Q3 | 3.86 Billion BRL | -12.38% |
2023 Q4 | 3.36 Billion BRL | -12.93% |
2023 Q2 | 4.41 Billion BRL | 65.95% |
2022 Q2 | 2.97 Billion BRL | 14.81% |
2022 Q3 | 2.49 Billion BRL | -16.2% |
2022 FY | - BRL | 83.05% |
2022 Q1 | 2.59 Billion BRL | 107.62% |
2022 Q4 | 1.81 Billion BRL | -27.07% |
2021 Q3 | 2.64 Billion BRL | -9.09% |
2021 Q2 | 2.91 Billion BRL | 829.33% |
2021 Q1 | 313.37 Million BRL | -89.14% |
2021 Q4 | 1.24 Billion BRL | -52.88% |
2021 FY | - BRL | -56.88% |
2020 Q1 | 3.28 Billion BRL | 5461.86% |
2020 Q3 | 3.37 Billion BRL | 206.08% |
2020 Q2 | 1.1 Billion BRL | -66.38% |
2020 Q4 | 2.88 Billion BRL | -14.6% |
2020 FY | - BRL | 203.99% |
2019 Q3 | 1.41 Billion BRL | 20.17% |
2019 FY | - BRL | -2.99% |
2019 Q4 | -61.25 Million BRL | -104.32% |
2019 Q2 | 1.18 Billion BRL | 22.21% |
2019 Q1 | 966.32 Million BRL | 42.71% |
2018 Q3 | 705.16 Million BRL | -3.62% |
2018 Q2 | 731.68 Million BRL | 38.81% |
2018 Q1 | 527.09 Million BRL | 4.76% |
2018 FY | - BRL | 53.43% |
2018 Q4 | 677.13 Million BRL | -3.97% |
2017 Q1 | 527.4 Million BRL | 50.78% |
2017 Q2 | 606.42 Million BRL | 14.98% |
2017 Q3 | 662.84 Million BRL | 9.3% |
2017 Q4 | 503.14 Million BRL | -24.09% |
2017 FY | - BRL | 26.67% |
2016 Q3 | 486.96 Million BRL | -12.15% |
2016 FY | - BRL | 19.09% |
2016 Q2 | 554.33 Million BRL | 32.46% |
2016 Q4 | 349.79 Million BRL | -28.17% |
2016 Q1 | 418.49 Million BRL | -6.91% |
2015 Q3 | 455.81 Million BRL | 16.61% |
2015 FY | - BRL | 90.58% |
2015 Q2 | 390.89 Million BRL | 74.66% |
2015 Q1 | 223.8 Million BRL | 2.54% |
2015 Q4 | 449.58 Million BRL | -1.37% |
2014 Q1 | 136.24 Million BRL | 0.0% |
2014 Q4 | 218.26 Million BRL | -4.41% |
2014 Q3 | 228.32 Million BRL | -3.26% |
2014 FY | - BRL | 33.86% |
2014 Q2 | 236.02 Million BRL | 73.23% |
2013 FY | - BRL | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kora Saúde Participações S.A. | 406.06 Million BRL | -2424.903% |
Oncoclínicas do Brasil Serviços Médicos S.A. | 1.16 Billion BRL | -777.812% |